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Abstract Mutations on human presenilins 1 and 2 cause
dominant early-onset familial Alzheimer’s disease (FAD).
Presenilins are polytopic transmembrane proteins endoproteoly-
tically processed in vivo to N- and C-terminal fragments (NTFs
and CTFs). The functional presenilin unit consists of a high
molecular weight complex that contains both fragments. Here
we show NTF:NTF, CTF:CTF and NTF:CTF interactions
by yeast two-hybrid and in vivo endoplasmic reticulum split-
ubiquitin assays. Our results also highlight the involvement of
HL1 ^ the hydrophilic loop between TMI and TMII ^ in the
NTF:NTF binding site. Besides, nine FAD-linked presenilin
mutations substantially affected HL1:HL1 binding. From the
evidence of NTF and CTF homodimerization, we propose the
contribution of two NTFs and two CTFs, instead of a single
NTF:CTF heterodimer, to the functional presenilin^Q-secretase
complex and that FAD mutations affect the assembly or stability
of this complex. ß 2001 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Alzheimer’s disease (AD) is the major neurodegenerative
dementia syndrome in humans. Although it has a complex
aetiology, a small proportion of AD cases show autosomal
dominant inheritance. Mutations in three genes, the amyloid
precursor protein (APP) and two members of the presenilin
family, PS1 and PS2, cause early-onset AD (also called fam-
ilial AD or FAD) [1,2]. Presenilins are polytopic transmem-
brane proteins, primarily located in the endoplasmic reticulum
(ER) and early Golgi [3], which show a high degree of evolu-
tionary conservation. Although the precise role of presenilins
has not yet been established, biochemical and biological stud-
ies suggest their involvement in many crucial cellular processes
such as calcium homeostasis, protein folding and tra⁄cking,
GSK-3L and tau metabolism, neuronal apoptosis and Q-secre-
tase cleavage of APP and Notch ([4,5] and references therein).
PS1 and PS2 are predominantly found in vivo as V27^28
kDa N-terminal (NTF) and V16^17 kDa C-terminal (CTF)
fragments. Full-length presenilin polypeptides are short-lived
molecules, rapidly degraded via proteasomes, in contrast to
NTFs and CTFs, which are much more stable [6]. The gen-
eration and accumulation of NTFs and CTFs are highly regu-
lated. Both fragments build up to saturable levels at 1:1 stoi-
chiometry, even when over-expressed [7,8]. In addition, full-
length presenilins contribute to low molecular weight com-
plexes (180 kDa), which develop into larger aggregates (250
kDa) in which the NTF and CTF heterodimerize [9^12]. This
heterodimerization is a prerequisite for the endoproteolytic
processing [13]. It has been proposed that the stable
NTF:CTF heterodimer is the biologically active complex [14].
To date, the domains responsible for presenilin complex
formation and other intramolecular interactions have not
been reported. We previously characterized the Drosophila
full-length presenilin (Psn) [15] and we now report the binding
between several presenilin domains by two-hybrid analysis.
Our data, also con¢rmed by the in situ split-ubiquitin assay
support the predicted NTF:CTF heterodimerization and also
reveal NTF:NTF and CTF:CTF homodimers. Furthermore,
from the two-hybrid analysis and the glutathione S-transfer-
ase (GST) pull-down binding assay we infer that the NTF
hydrophilic loop facing the ER between TMI and TMII ac-
counts for the NTF:NTF interaction and that this binding is
altered by FAD-linked presenilin mutations.
2. Materials and methods
2.1. DNA constructs
The entire sequence and six fragments of the Drosophila presenilin
gene (Psn) were subcloned in-frame into the yeast two-hybrid pACT2
(prey) and pAS2-1 (bait) vectors (Matchmaker Yeast Two-hybrid sys-
tem II, Clontech). The primers used for PCR ampli¢cation of each
Psn fragment and their position with respect the protein are listed in
Table 1.
For GST pull-down experiments, PSN HL1 (the 32 aa hydrophilic
loop between TMI and TMII) was fused to GST (GST-HL1). The
second construct containing the PSN-HL1 fused to the HA (hemag-
glutinin) epitope and GST (GST-HA-HL1) was obtained using a HA-
HL1 fragment obtained from the HL1pACT2 construct.
Site-directed mutagenesis was performed by PCR ampli¢cation us-
ing the full-length Psn template as described [16]. Mutagenic oligonu-
cleotides are listed in Table 1.
Split-ubiquitin constructs containing Drosophila PSN NTF (aa 1^
322) and CTF (aa 321^541) were generated as follows: A yeast cen-
tromeric plasmid (derived from pRS415, kindly provided by B. Pin‹a)
containing the ADH1 promoter and termination expression cassettes
was constructed to clone either PSN NTF or PSN CTF directly fused
to Cub-ProtA-LexA-Vp16. The gene fusion Cub-ProtA-LexA-Vp16
was obtained from pRS375 (kindly provided by I. Stagljar). The fu-
sions between PSN NTF and PSN CTF to Cub generated the peptide
linkers GSTSSRVEGSTMSG and SSSRVESGGSTMSG, respec-
tively. The fusion constructs containing NubG fused to PSN NTF
and to PSN CTF were cloned into pRS396 (kindly given by I. Stagl-
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jar) by substituting ALG5-Nub as a cassette. The expression from
these Nub-PSN-derived fusions was driven by the CUP1 promoter.
The fusions NubG-PSN NTF and NubG-PSN CTF generated the
short peptide linker IIEF.
The identity and reading frame of all DNA constructs was con-
¢rmed by sequencing with the Dye Terminator Cycle Sequencing
Ready Reaction Kit (Perkin Elmer) and a 377 ABI PRISM sequencer.
2.2. Yeast two-hybrid assay
Yeast strains Y190 and CG-1945 were co-transformed with prey
and bait plasmids derived from pACT2 and pAS2-1 using the stan-
dard lithium acetate procedure. Transformants were selected for
growth on SD-His/-Trp/-Leu plates with 25 mM 3-aminotriazole for
the Y190 strain and 5 mM for the CG-1945. Y190 transformants were
assayed for L-galactosidase activity by ¢lter-lift assay using X-gal as a
substrate. Quanti¢cation of L-galactosidase activity was achieved by a
liquid culture L-galactosidase assay using ONPG as substrate. Nega-
tive controls were performed using pLAM5’ (Clontech) and empty
prey and bait vectors. All protocols were according to the manufac-
turer’s instructions (Clontech).
2.3. Split-ubiquitin assay
Yeast strain L40 was co-transformed with the corresponding Nub-
and Cub- derived constructs using the lithium acetate procedure.
Transformants were selected for growth on SD-His/-Trp/-Leu with
25 mM 3-aminotriazole and 0.2 mM Cu2.
2.4. Yeast protein extractions and immunoblotting
Detection of correct expression of GAL4-fusion proteins in the two-
hybrid assay was performed by growing the corresponding clones
bearing the two assayed constructs, until 0.4^0.6 OD. Protein extracts
were obtained following the speci¢cations of the plasmid supplier
(Clontech), heated at 55‡C, electrophoresed and immunodetected us-
ing the monoclonal antibody HA.11 (BAbCO) and a polyclonal anti-
body against GAL4-BD (Santa Cruz) for detecting GAL4-AD and
GAL4-BD protein fusions, respectively. In the split-ubiquitin assays,
yeast cells were grown in 25 ml of the corresponding rich or selective
media up to 1 O.D., harvested by centrifugation, washed twice with
1 vol of distilled water and ¢nally resuspended in 150 Wl of cold lysis
bu¡er (100 mM Tris^HCl, pH 7.5; 150 mM NaCl; 2 mM EDTA; 1%
digitonin; 0.5% NP-40 and protease inhibitors). Cells were mechan-
ically broken with glass beads and the protein extract was recovered
after centrifugation (4500 rpm in a microfuge). After a second cen-
trifugation (13 000 rpm in a microfuge) for 20 min, pellets and super-
natants were treated separately. Pellets containing insoluble and mem-
brane associated proteins were directly resuspended in protein loading
bu¡er solution for SDS^PAGE gels, whereas supernatants were pre-
cipitated with 5 vol of cold acetone (1 h at 320‡C), centrifuged, air-
dried and resuspended in protein loading bu¡er solution. Protein
samples were loaded onto an SDS^PAGE electrophoresis gel after
heating for 15 min at 50‡C, blotted onto a polyvinylidene £uoride
(PVDF) membrane, immunodetected with Anti-ProtA (Sigma) and
visualized using SuperSignal (Pierce) reagents.
2.5. In vitro binding assay
GST-HL1, GST-HA-HL1 and GST constructs (derived from
pGEX4T-1) were transformed into BL21 cells. Cells were grown over-
night at 37‡C, diluted 1:10 and grown for 1 h at 30‡C. After induction
with 1 mM IPTG for 90 min, cells were sonicated and the fusion
proteins were a⁄nity-bound to glutathione Sepharose beads, follow-
ing the manufacturer’s instructions (Amersham Pharmacia Biotech).
Puri¢ed HA-HL1 was obtained after thrombin digestion of the im-
mobilized GST-HA-HL1 protein as described [17]. Approximately
2 Wg of the immobilized GST and GST-HL1 proteins were mixed
with HA-HL1 in 600 Wl of Bead Binding Bu¡er (20 mM HEPES,
pH 7.9, 100 mM KCl, 1 mM MgCl2, 10 WM ZnCl2, 0.5% Triton X-
100, 10% glycerol, 2 mM dithiothreitol and 1 mM phenylmethylsul-
fonyl £uoride). After incubation for 2 h at 4‡C under gentle mixing,
beads were washed three times in 500 Wl of Bead Binding Bu¡er,
eluted in 2UTris^tricine protein sample bu¡er and loaded onto a
20% SDS^polyacrylamide gel. The protein gels were blotted onto a
PVDF ¢lter, immunodetected with monoclonal antibody HA.11
(BAbCO) and visualized by enhanced chemoluminescence (Amersham
Pharmacia Biotech).
3. Results and discussion
Positive NTF:CTF heterodimerization is shown (Fig. 1a),
in agreement with previous ¢ndings on human and mouse
cells mainly by co-immunoprecipitation and protein fraction-
ation on glycerol velocity gradients [9,10,12,18,19]. This inter-
action occurred either in the absence or presence of an alter-
natively spliced exon [15] encoding 14 aa embedded in the
cytoplasmic hydrophilic loop (HL6). Besides, the hydrophobic
transmembrane domains of the NTF and CTF peptides did
not interfere with transport to the nucleus nor with proper
interaction as shown by the positive binding in the two-hybrid
analysis (Fig. 1a), even though an ER location has been re-
ported for these peptides. To identify the binding site for the
NTF:CTF interaction, constructs encoding shorter peptide
domains were analyzed. A shorter NTF containing the hydro-
philic loop (N-loop, aa 1^100) interacted with either the HL6
cytosolic hydrophilic loop of CTF or the C-terminal hydro-
phobic segment (the last 38 aa), after TMVIII (C-loop) (Fig.
1a). Both interactions might be due either to a speci¢c require-
Table 1
List of primers used in the experiments described in this work (PCR ampli¢cation of Psn-domains and site-directed mutagenesis)
Oligonucleotide Sequence First aa encoded
CompF 5P-GGAATTCATGGCTGCTGTCAATCT-3P 1
CompR 5P-CGGGATCCTATAAACACCTGCTTGGC-3P 541
NloopR 5P-CGGGATCCCCCGTATTTCAGGCCCTG-3P 100
HL1F 5P-GGAATTCAACTCCATCAGCTTCTAC-3P 123
HL1R 5P-CGGGATCCGGCACTCCAGAACTTAAC-3P 154
HL6F 5P-GGAATTCTCGCCAAGAGGACCCCTC-3P 285
Loop6R 5P-CGGGATCCGCCACGTTCTTCTTGCCC-3P 454
NterR 5P-CGGGATCCAACAGTGTTTACAAGTGC-3P 322
CterF 5P-GGAATTCACTGTTACGCCGCAGCAA-3P 321
CterHLF 5P-GGAATTCCGCAAGGCGCTACCCGCC-3P 503
Y137H 5P-CTATCTCCTCCACACACCTTTC-3P site-directed mutagenesis
Y137C 5P-CTATCTCCTCTGCACACCTTTC-3P site-directed mutagenesis
Y137P 5P-CTATCTCCTCCCCACACCTTTC-3P site-directed mutagenesis
E142K 5P-ACCTTTCCATAAACAATCGCCCG-3P site-directed mutagenesis
E142D 5P-ACCTTTCCATGATCAATCGCCCG-3P site-directed mutagenesis
E142W 5P-ACCTTTCCATTGGCAATCGCCCG-3P site-directed mutagenesis
T138N 5P-TCTCCTCTACAACCCTTTCCAT-3P site-directed mutagenesis
P139L 5P-CCTCTACACACTTTTCCATGAA-3P site-directed mutagenesis
Mutations are underlined.
F: Forward oligonucleotide; R: reverse oligonucleotide.
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ment for NTF:CTF binding or to a ‘sticky’ nature of the
N-loop itself, as the interacting segments were very di¡erent
in their hydropathic pro¢le. Our data on other positive inter-
actions of this N-loop with several PSN peptides (data not
shown) would support the latter. An immunodetection show-
ing correct expression of all the tested PSN peptides when
fused to the GAL4-BD and GAL4-AD domains validated
our previous results. (Fig. 1b).
We also tested NTF and CTF ability to form complexes
other than the NTF:CTF heterodimer. The two-hybrid assay
allowed to analyze NTF and CTF homodimerization, very
di⁄cult to detect otherwise. The strong interactions shown
Fig. 1. a: Two-hybrid analyses of PSN fragments. The constructs encoding di¡erent domains of PSN listed were assayed in pairs (as shown).
Histidine independent growth was tested in plates lacking histidine and supplemented with 5 mM 3-aminotriazole (3AT) in yeast strain CG-
1945. L-Galactosidase activity was shown with the ¢lter-lift assay and X-gal as substrate in yeast strain Y190. +,3 indicate the strength of the
interaction. a: reverse experiment gave inconsistent values; b: reverse con¢rmatory values were obtained. Black boxes depict transmembrane
domains. b: Immunodetection of all the tested PSN fragments when fused to the GAL4-BD (A) and GAL4-AD (B) domains. The immunoblot
of the PSN peptides fused to the GAL4 domains rendered the expected size band (indicated by an asterisk), although in some cases other
bands were also detected, corresponding to protein aggregates or to protein degradation. c: In vitro binding assay. GST-HL1 and GST alone
were bound to glutathione Sepharose beads and mixed with puri¢ed HL1-HA. After incubation and washes, samples were resolved on 20%
Tris^tricine polyacrylamide gel, blotted onto a PVDF membrane and immunodetected with anti-HA. Lane 1: Puri¢ed HL1-HA (5% of the
amount used in the binding assays; control); 2: GST alone (negative control), HL1-HA was not retained; 3: GST-HL1, retained HL1-HA.
d: Quanti¢cation of L-galactosidase activity. Yeast strain Y190 co-transformed with mutant and wild-type (wt) HL1pAS or HL1pACT was
grown on selective medium. L-Galactosidase activity was quanti¢ed using ONPG as substrate. Values obtained for each pair of constructs (¢ve
to 10 replicas) are represented with respect to wt HL1pAS/HL1pACT clones, which represent the 100% activity. Black bars show heterozygous
combinations: pAS carried the mutant HL1 and pACT, the wt HL1. Striped bars show homozygous mutations: both HL1pAS and HL1pACT
constructs bore the mutant versions of HL1.
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suggested the formation of NTF:NTF and CTF:CTF homo-
dimers (Fig. 1a). Again, the latter was una¡ected by the 14 aa
enclosed in the alternative exon. In order to identify the pep-
tides responsible for NTF homodimerization, several shorter
constructs were tested. Interestingly, the HL1 peptide corre-
sponding to the 32 aa ER hydrophilic turn between TMI and
TMII produced a clear HL1:HL1 homodimer (Fig. 1a),
whereas the N-loop (¢rst 100 aa) yielded inconsistent results
and was not further considered. Additional positive and neg-
ative controls were assayed to con¢rm the speci¢city of all the
interactions (Fig. 1a and data not shown). Finally, attempts to
de¢ne the domains responsible for CTF:CTF homodimeriza-
tion after dissecting CTF in several domains were not success-
ful (Fig. 1a). These negative results were not due to incorrect
expression of the fusion proteins as shown by immunodetec-
tion (Fig. 1b). As transmembrane domains had not been in-
cluded in these constructs, their contribution to homodimer
binding could not be discarded.
To con¢rm HL1:HL1 homodimerization, a GST pull-down
assay was performed. Of the two GST-HL1 constructs, the
prey contained an additional HA epitope fused to HL1 (GST-
HA-HL1) to allow discrimination from GST-HL1 (bait).
After binding to glutathione beads, the GST-HA-HL1 protein
was proteolysed with thrombin and the isolated HA-HL1 pep-
tide was incubated with matrix-bound GST-HL1 (bait). After
immunodetection of HA-HL1 with an anti-HA antibody, the
speci¢city of the HL1:HL1 interaction was shown (Fig. 1c).
Interestingly, nine FAD-linked missense mutations are clus-
Fig. 2. a: The split-ubiquitin constructs (1) PSN NTF-Cub-ProtA-LexA-Vp16 and (2) NubG-PSN NTF were cloned in the yeast expression
vectors pRS415 and pRS396, respectively. The topology of the fusion protein is also shown. Similar, PSN CTF constructs were also con-
structed to be tested in this assay (the ¢gures are not depicted). The original split-ubiquitin constructs were kindly provided by I. Stagljar.
b: The split-ubiquitin assay was performed by co-transformation of yeast strain L40 with the following pairs of fusion proteins: (1) NubG-
Alg5 and PSN NTF-Cub-ProtA-LexA-Vp16 (negative control); (2) NubG-Alg5 and PSN CTF-Cub-ProtA-LexA-Vp16 (negative control);
(3) NubG-PSN NTF and PSN NTF-Cub-ProtA-LexA-Vp16; (4) NubG-PSN CTF and PSN CTF-Cub-ProtA-LexA-Vp16; (5) NubG-PSN
NTF and PSN CTF-Cub-ProtA-LexA-Vp16; (6) NubG-PSN CTF and PSN NTF-Cub-ProtA-LexA-Vp16. (A) Three days growth on SD-Leu/
Trp/His+3-aminotriazole (3AT) 25 mM; (B) X-Gal ¢lter-lift assay. Four di¡erent clones were tested for each group of constructs. c: Immuno-
detection of the split-ubiquitin protein products using anti-ProtA on a Western blot of the protein cell extracts separated in pellet (lanes 1, 3,
5 and 7) and soluble (lanes 2, 4, 6 and 8) fractions. Lanes 1 and 2: untransformed yeast strain L40 (negative control); lanes 3 and 4: yeast
expressing the PSN NTF-Cub-ProtA-LexA-Vp16 protein where only the precursor peptide is produced; lanes 5 and 6: yeast co-expressing
NubG-PSN NTF and PSN NTF-Cub-ProtA-LexA-Vp16 proteins, where after the interaction of both NTF fragments and reconstitution of
ubiquitin, the ProtA-LexA-Vp16 peptide is cleaved o¡; lanes 7 and 8: yeast co-expressing NubG-mutant (EK) PSN NTF and wt PSN NTF-
Cub-ProtA-LexA-Vp16 proteins, where due to impaired NTF interaction, the ProtA-LexA-Vp16 peptide is cleaved o¡ less e⁄ciently (some un-
cleaved precursor still remained in the insoluble fraction). d: Quanti¢cation of L-galactosidase activity using ONPG as substrate. Yeast strain
L40 was co-transformed with PSN NTF-Cub-ProtA-LexA-Vp16 and EK or wild-type (wt) NubG-PSN NTF and grown on selective medium.
Values for each pair of constructs (6 replicas) are represented with respect to wt (100% activity).
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tered in the HL1 domain, a¡ect seven out of the 32 aa, and
¢ve of those correspond to conserved residues between human
and Drosophila. To determine whether these mutations alter
the HL1:HL1 interaction, we reproduced each mutation by
site-directed mutagenesis. Wild-type and mutated HL1 con-
structs were quanti¢ed for L-galactosidase activity on
ONPG following the yeast two-hybrid analysis. The Drosophi-
la mutations analyzed were Y138H (Y115 in human PS1),
Y138C (Y115 in human PS1), T139N (T116 in human PS1),
P140L (P117 in human PS1), E143D (E120 in human PS1)
and E143K (E120 in human PS1), reviewed in [5]. We also
assayed two additional mutations, whose severity was pre-
dicted on the basis of aa similarities [20,21] : Y138P and
E143W. As expected, all mutations clearly a¡ected the inter-
action, either increasing or decreasing the a⁄nity of the bind-
ing (Fig. 1d). Homodimerization was similarly a¡ected when
mutants were in homozygous or heterozygous combination, in
agreement with the dominant inheritance associated to these
ADs causing alleles (Fig. 1d). Extreme interaction variations
were observed with the predicted two more severe mutations
Y138P and E143W (six-fold increase and 20-fold decrease,
respectively). Secondary structure prediction of the HL1 seg-
ment by the network protein sequence analysis (http://
pbil.ibcp.fr) identi¢ed an extended strand (residues 11^15 of
HL1) amidst a coiled-coil segment. Introduction of FAD-
linked mutations in HL1 a¡ected the extension and location
of the extended strand, therefore linking variations in binding
a⁄nity to secondary structure. Although in some cases we
have found positive correlation between FAD-onset age and
aa substitutions (Table 2), clear cut genotype^phenotype cor-
relations could be blurred by the di¡erent genetic background
of each patient, even in a single family. In the same way, other
attempts to establish a relationship between amyloid AL42
peptide secretion and FAD age of onset have been unsuccess-
ful [22].
Artefacts in the two-hybrid analysis could arise from incor-
rect protein folding or improper localization as they contain
several highly hydrophobic domains and are usually anchored
in the ER and Golgi. To discard this possibility, the yeast
split-ubiquitin system, based on the reconstitution of a full-
length ubiquitin from the N-terminal (Nub) and C-terminal
(Cub) domains [23], was used to show that PSN NTFs and
CTFs formed homo- and heterodimers when anchored in the
ER. The Nub and Cub fragments were expressed as indepen-
dent fusions with the pressumptive interacting proteins (Fig.
2a). In addition, the C-terminal ubiquitin moiety (Cub) was
fused to an immunodetectable peptide (ProtA) and a tran-
scription factor (LexA-Vp16) (Fig. 2a). Upon in situ pro-
tein^protein interaction, the reconstituted ubiquitin would
be cleaved by the numerous cellular UBPs (ubiquitin speci¢c
proteases), and the reporter genes (in our case, HIS3 and
lacZ) would be activated by the released transcription factor.
To avoid di¡usion of uncleaved Cub-ProtA-LexA-Vp16 pre-
cursor into the nucleus, this gene fusion was inserted into a
low-expression centromeric vector. This in vivo assay allows
(a) proper subcellular localization of the proteins analyzed,
(b) detection of homodimers without the need to use epitopes,
(c) easy co-transfection and simultaneous protein expression
and ¢nally, (d) reliable quanti¢cation of the interactions of
wild-type and mutant proteins by the use of sensitive report-
ers.
Yeast strain L40 co-transformed with the corresponding
PSN-derived fusion constructs containing Cub-ProtA-LexA-
Vp16 and NubG (Fig. 2a), grew on plates lacking tryptophan,
leucine and histidine and gave blue staining in X-gal assays
(Fig. 2b). Our results clearly con¢rmed positive NTF:NTF,
CTF:CTF and NTF:CTF when anchored in the ER (Fig. 2b).
Further, the speci¢city of the interaction was con¢rmed by the
absence of growth in yeast co-transformed with either PSN
NTF-Cub-ProtA-LexA-Vp16 or PSN CTF-Cub-ProtA-LexA-
Vp16 and another yeast ER transmembrane protein (Alg5-
NubG) [23] (Fig. 2b, negative controls). The cleavage of the
ProtA-LexA-Vp16 transcription factor by UBPs after NubG^
Cub reconstitution was clearly con¢rmed by immunodetection
(Fig. 2c). The cleaved ProtA-LexA-Vp16 product (52 kDa)
was detected in the soluble protein fraction, while the un-
cleaved precursor PSN NTF-Cub-ProtA-LexA-Vp16 (88
kDa) was only present in the pellets containing insoluble or
membrane associated proteins, thus indicating a correct local-
ization of the presenilin fusion in the ER. This result agreed
with previous reports showing that heterologous presenilins
bound the ER membrane in yeast [24,25]. Only the uncleaved
precursor PSN NTF-Cub-ProtA-LexA-Vp16 was detected in
yeast transformed with this construct alone (Fig. 2c, compare
lanes 3 and 4). In contrast, when yeast was co-transformed
with the gene fusions containing NTF interacting partners, the
cleaved transcription factor clearly appeared in the soluble
fraction (Fig. 2c, compare lanes 6 and 8). In addition, we
also assessed the e¡ect of FAD-linked mutations in
NTF:NTF in situ homodimerization, by introducing the sub-
stitution E143K (corresponding to human PS1 E120K Alz-
heimer’s mutation) using site-directed mutagenesis. Clearly,
the NTF:NTF interaction was impaired by the mutation, as
the cleavage from the precursor was less e⁄cient and some
uncleaved precursor remained in the insoluble fraction (Fig.
2c, lanes 7 and 8). The e¡ect of this mutation on NTF ho-
modimerization was further con¢rmed by quanti¢cation of L-
galactosidase activity. The mutant NTF clearly showed a de-
crease (80% of lacZ activity after six replicas) in binding af-
¢nity with respect to wild-type NTF (Fig. 2d). The higher
decrease in the mutant HL1:HL1 interaction (detected by
two-hybrid analysis, Fig. 1d) than in the mutant NTF:NTF
(detected by the split-ubiquitin assay, Fig. 2d) could be ex-
plained by a more restricted conformation of the HL1 domain
when £anked by the two transmembrane helices of the NTF
peptide. In fact, if we consider that mutations causing AD are
neither lethal nor strongly deleterious, a large e¡ect of the
mutations on presenilin function should not be expected.
According to our data, interactions between the di¡erent
subdomains (NTF:CTF, NTF:NTF, CTF:CTF) would be
Table 2
Genotype^phenotype correlation between the mutation e¡ect on the
interaction and FAD-onset age
Mutation Age at onset L-Gal activity with respect to wild-type
heterozygous homozygous
Y115C 42 U2.74 U1.53
Y115H 36 U4.00 U5.60
T116N 35^41 U2.35 U2.56
P117L 24^31 U0.26 U0.40
E120D 43^48 U1.29 U1.00
E120K 35^39 U0.10 U0.16
Interaction value between wild-type constructs is arbitrarily consid-
ered as 1.
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required for the correct assembly of a hypothetic tetramer,
with two NTFs and two CTFs instead of a single NTF:CTF
heterodimer (Fig. 3), strongly suggesting a new organization
for the presenilin functional complex. Irrespective of whether
the presenilin is the long-sought Q-secretase or a necessary
partner for the Q-secretase activity, our hypothesis supports
the notion that formation of the presenilin tetramer would
be a crucial step for the assembly or stability of the high
molecular weight presenilin^Q-secretase complex. Subtle
changes in presenilin binding a⁄nity caused by some FAD-
linked mutations could result in dysfunction of the Q-secretase
activity, thus triggering the cellular processes eventually lead-
ing to AD.
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